Angiotensin II type 2 receptor agonists where should they be applied?

Expert Opinion on Investigational Drugs

Volumn 21, Issue 6, 2012, Pages 763-766

  Steckelings, Ulrike Muscha ^a   Unger, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Angiotensin; AT2R; Cardiology; Reninangiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANTIINFLAMMATORY AGENT; COMPOUND 21; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RENIN INHIBITOR; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; ALZHEIMER DISEASE; ANEURYSM; AUTOIMMUNE DISEASE; BLOOD PRESSURE; COGNITIVE DEFECT; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IN VIVO STUDY; KIDNEY DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; STROKE; VASOCONSTRICTION; VASODILATATION;

ANGIOTENSIN II; ANIMALS; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84861074025     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2012.681046     Document Type: Review

References (16)

1. Verdonk K, Danser AHJ, van Esch JHM. Angiotensin II type 2 receptor agonists: where should they be applied? Expert Opin Investig Drugs 2012;21:501-13
2. Wan Y, Wallinder C, Plouffe B, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004;47:5995-6008 (Pubitemid 39507341)
3. Habashi JP, Doyle JJ, Holm TM, et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 2011;332:361-5
4. Matavelli LC, Huang J, Siragy HM. Angiotensin AT2 receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 2011;57:308-13
5. Gelosa P, Pignieri A, Fandriks L, et al. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens 2009;27:2444-51
6. Paulis L, Becker STR, Lucht K, et al. Direct angiotensin II type 2 receptor stimulation in Nomega-Nitro-LArginine-Methyl Ester-induced hypertension: the effect on pulse wave velocity and aortic remodelling. Hypertension 2012;59:485-92
7. Rehman A, Leibowitz A, Yamamoto N, et al. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2012;59:291-9
8. Jing F, Mogi M, Sakata A, et al. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab 2012;32:248-55
9. McCarthy CA, Vinh A, Callaway JK, Widdop RE. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 2009;40:1482-9
10. Rompe F, Artuc M, Hallberg A, et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension 2010;55(4):924-31
11. Wu L, Iwai M, Li Z, et al. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. Mol Endocrinol 2004;18(3):666-78 (Pubitemid 38328210)
12. Steckelings UM, Widdop RE, Paulis L, Unger T. The angiotensin AT2 receptor in left ventricular hypertrophy. J. Hypertens 2010;28(Suppl 1):S50-5
13. Bosnyak S, Welungoda IK, Hallberg A, et al. Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol 2010;159(3):709-16
14. Hilliard LM, Jones ES, Steckelings UM, et al. Sex-specific influence of Angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension 2012;59(2):409-14
15. Kaschina E, Grzesiak A, Li J, et al. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 2008;118(24):2523-32
16. Gao J, Zhang H, Le KD, et al. Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats. Am J Hypertens 2011;24(6):724-30